Does AMLODIPINE Cause Hyperthyroidism? 179 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Hyperthyroidism have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.3% of all adverse event reports for AMLODIPINE.
179
Reports of Hyperthyroidism with AMLODIPINE
0.3%
of all AMLODIPINE reports
36
Deaths
113
Hospitalizations
How Dangerous Is Hyperthyroidism From AMLODIPINE?
Of the 179 reports, 36 (20.1%) resulted in death, 113 (63.1%) required hospitalization, and 31 (17.3%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 179 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
Which AMLODIPINE Alternatives Have Lower Hyperthyroidism Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL